Human Subjects in Research

University policy and federal law (45 CFR 4, 21 CFR Parts 50 and 56) require that all research involving human subjects, biospecimens, and/or identifiable private information , must be reviewed and approved by an Institutional Review Board (IRB) prior to the start of any research activities.

IRBNet

IRBNet is the protocol management system that offers secure, web-based collaboration tools to support the design, management, review and oversight of research involving human subjects.

Log into IRBNet

IRBNET Submission Instructions

Educational Activities that ARE Human Subjects Research: If an instructor determines that there is a possibility that a student’s proposed research project may result in a formal presentation or publication, he/she should recommend that the student submit the project for IRB review before beginning the study.


Educational Activities that ARE NOT Human Subjects Research: All human subjects research requires prior institutional approval, but not all data gathering by students constitutes human subjects research. The definition of research below establishes that an activity must be designed with the intent to develop or contribute to “generalizable knowledge.” Classroom activities designed to teach research techniques or allow students to practice those techniques are not considered research with human subjects and are not required to be submitted to the UD IRB for review.

Simulations of human experimentation and course-assigned data collection do not constitute human subjects research if all of the following conditions are true:

  • activities are designed for educational purposes only;
  • the data will not be generalized outside the classroom (reporting of data within the class is acceptable because the activities were performed solely for teaching purposes);
  • the data will not result in a master’s thesis or doctoral dissertation; and
  • the student volunteers or other participants are clearly informed that the activities are an instructional exercise, and not actual research.

Changes to the Updated Common Rule Effective Date

More Information

Upcoming Events
Training
Human Subjects Protection (HSP)
Training in the protection of human subjects in research is required for all university members (i.e., faculty, students, researchers and staff), and collaborators, who will directly interact with research participants or have access to identifiable private information.

Good Clinical Practice (GCP)
Training in Good Clinical Practice (GCP) must be completed by all research team members involved in NIH-supported clinical trials.

Definitions

Clinical Trial
Exact definitions of what type of studies constitute a clinical trial are different depending on the applicable oversight agency. More details on clinical trials can be found below.
Educational Activities
Educational Activities that ARE Human Subjects Research: If an instructor determines that there is a possibility that a student’s proposed research project may result in a formal presentation or publication, he/she should recommend that the student submit the project for IRB review before beginning the study.

Educational Activities that ARE NOT Human Subjects Research: All human subjects research requires prior institutional approval, but not all data gathering by students constitutes human subjects research. The definition of research below establishes that an activity must be designed with the intent to develop or contribute to “generalizable knowledge.” Classroom activities designed to teach research techniques or allow students to practice those techniques are not considered research with human subjects.

Simulations of human experimentation and course-assigned data collection do not constitute human subjects research if the activities are designed for educational purposes only; and

  • the data will not be generalized outside the classroom (reporting of data within the class is acceptable because the activities were performed solely for teaching purposes); and
  • the data will not result in a master’s thesis, doctoral dissertation, poster session, abstract or other publication or presentation; and
  • the student volunteers or other participants are clearly informed that the activities are an instructional exercise and not actual research.
Human subject
A living individual about whom an investigator (whether professional or student) conducting research:

  • Obtains information or biospecimens through intervention or interaction with the individual and uses, studies, or analyzes the information or biospecimens, or
  • Obtains, uses, studies, analyzes, or generates identifiable private information or identifiable biospecimens.
Intervention
Includes both physical procedures by which data are gathered (for example, venipuncture) and manipulations of the subject or the subject’s environment that are performed for research purposes.
Interaction
Includes communication or interpersonal contact between investigator and subject.
Minimal Risk
The probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests.
Private information
Private information includes information about behavior that occurs in a context in which an individual can reasonably expect that no observation or recording is taking place, and information that has been provided for specific purposes by an individual and that the individual can reasonably expect will not be made public (e.g., a medical record).

Identifiable private information is private information for which the identity of the subject is or may readily be ascertained by the investigator or associated with the information.

An identifiable biospecimen is a biospecimen for which the identity of the subject is or may readily be ascertained by the investigator or associated with the biospecimen.

Research
A systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge. Activities that meet this definition constitute research for purposes of this policy, whether or not they are conducted or supported under a program that is considered research for other purposes. For example, some demonstration and service programs may include research activities.

HIPAA

In the context of research, the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule establishes the conditions under which protected health information (PHI) may be used or disclosed by covered entities for research purposes. The Privacy Rule protects the privacy of individually identifiable health information, while at the same time ensuring that researchers continue to have access to medical information necessary to conduct research.
How the Rule Works:
Under HIPAA, researchers may obtain, create, use, disclose and/or otherwise access PHI for research purposes through one of the following methods:

  • By obtaining individual authorization: An Authorization is basically an individual’s written permission or consent to use his or her PHI for research purposes. HIPAA requires that an Authorization be written in plain language and contain certain “core” elements. Research authorizations may be combined with an informed consent form or set forth in a separate Authorization document. See forms and templates in IRBNet for further guidance on what to include in a HIPAA Authorization for research.
  • By obtaining IRB waiver or alteration of the authorization requirement: The following three criteria must be satisfied for an IRB or Privacy Board to approve a waiver of authorization under the Privacy Rule:
    1. The use or disclosure of protected health information involves no more than a minimal risk to the privacy of individuals, based on, at least, the presence of the following elements:
      • an adequate plan to protect the identifiers from improper use and disclosure;
      • an adequate plan to destroy the identifiers at the earliest opportunity consistent with conduct of the research, unless there is a health or research justification for retaining the identifiers or such retention is otherwise required by law; and
      • adequate written assurances that the protected health information will not be reused or disclosed to any other person or entity, except as permitted by this subpart;
    2. The research could not practicably be conducted without the waiver or alteration; and
    3. The research could not practicably be conducted without access to and use of the protected health information.
  • By using de-identified information: Health information that has been “de-identified” in a manner required by HIPAA is not considered PHI and may be used or disclosed for research purposes without individual authorization. De-identification can be done by removal of all 18 elements that could be used to identify an individual and/or the individual’s relatives as described in the Privacy Rule. Alternatively, de-identification may be established by the use of statistical methods.
  • By using limited data sets with a data use agreement: A limited data set is described as health information that excludes certain listed direct identifiers but that may include city, state, ZIP Code, elements of date and other numbers, characteristics or codes not listed as direct identifiers. It is the responsibility of the researcher and the party releasing the PHI to have in place and maintain a copy of a data use agreement that meets HIPAA requirements.
  • By using only decedents’ information, with certain assurances
  • By using PHI for purposes preparatory to research, with certain assurances and with no removal of any PHI from the covered entity (physically or electronically).
Human Subjects: IRB Review Types and Procedures

IRB Overview

Exemptions

Exemptions Effective as of 1/21/2019

Research meeting the criteria described in the following categories can be deemed exempt from regulatory requirements imposed by the Common Rule. Exempt review determinations MUST be made by the IRB office and require the submission of a research protocol to the IRB.

CATEGORY

  1. Research, conducted in established or commonly accepted educational settings, that specifically involves normal educational practices that are not likely to adversely impact students’ opportunity to learn required educational content or the assessment of educators who provide instruction.
     
    This category would apply to most research on regular and special educational instructional strategies, and research on the effectiveness or the comparison among instructional techniques, curricula, or classroom management methods.

    • Established or commonly accepted educational settings are settings where one would go in order to have an educational experience that is regularly offered, or that is commonly accepted in a specific culture or population.
    • Normal educational practices are activities that could occur in the specific educational setting regardless of whether the research is conducted. This includes a variety of activities that normally occur in the classroom or that are considered “best practice”. Examples include established teaching methods (not considered to be experimental) or curriculum, and commonly accepted classroom management techniques that are planned and implemented by the classroom teacher.
  2. Educational tests, surveys, interviews, observations of public behavior: Research that only includes interactions involving educational tests (cognitive, diagnostic, aptitude, achievement), survey procedures, interview procedures or observation of public behavior (including visual or auditory recordings) if at least one of the following criteria is met:
    1. The information obtained is recorded by the investigator in such a manner that the identity of the human subjects cannot be readily ascertained, directly or through identifiers linked to the subjects.
    2. Any disclosure of the human subjects’ responses outside the research would not reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects’ financial standing, employability, educational advancement, or reputation.
    3. The information obtained is recorded by the investigator in such a manner that the identity of the human subjects can readily be ascertained, directly or through identifiers linked to the subjects, and an IRB conducts a limited IRB review to make the determination that, when appropriate, there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data.

     

    • Research involving children does not qualify for this exempt category if: (1) the research involves surveys, interviews, and/or observations of public behavior when the research team participates in the activities being observed, or (2) if Limited IRB Review is required.
    • Observation of public behavior must not be influenced by the investigator and cannot involve an intervention (e.g., research involving observation of public behavior does not qualify for this exemption if the investigator intervenes with subjects by asking a question or posting a comment with on a public chat room with the intent to change the environment to observe behavior changes.
  3. Benign behavioral interventions. Research involving benign behavioral interventions in conjunction with the collection of information from an adult subject through verbal or written responses (including data entry) or audiovisual recording if the subject prospectively agrees to the intervention and information collection and at least one of the following criteria is met:
    1. The information obtained is recorded by the investigator in such a manner that the identity of the human subjects cannot readily be ascertained, directly or through identifiers linked to the subjects;
    2. Any disclosure of the human subjects’ responses outside the research would not reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects’ financial standing, employability, educational advancement, or reputation; or
    3. C. The information obtained is recorded by the investigator in such a manner that the identity of the human subjects can readily be ascertained, directly or through identifiers linked to the subjects, and an IRB conducts a limited IRB review to determine that the research (when appropriate) has adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data.

     

    Research involving children does not qualify for this exempt category.

    • Benign behavioral interventions are defined as brief in duration, harmless, painless, not physically invasive, not likely to have a significant adverse lasting impact on the subjects, and the researcher has no reason to think that the subjects will find the interventions/ interactions/observations to be offensive or embarrassing.
    • Prospective agreement. Subjects must be asked to agree to participate in the research. This is not the same as the requirement for consent, or for documentation of consent. The request may be tailored to the nature of the specific study.
    • Deception. If the research involves deceiving the subjects regarding the nature or purposes of the research, this exemption is not applicable unless the subjects authorizes the deception through a prospective agreement to participate in research in circumstances in which the subject is informed that he or she will be unaware of or misled regarding the nature or purposes of the research.
  4. Secondary research uses of identifiable private information or identifiable biospecimens for which consent is not required, if at least one of the following criteria is met:
    1. Publicly available. The identifiable private information or identifiable biospecimens are publicly available.
    2. Not identifiable as recorded. Information, which may include information about biospecimens, is recorded by the investigator in such a manner that the identity of the human subjects cannot readily be ascertained directly or through identifiers linked to the subjects, the investigator does not contact the subjects, and the investigator will not re-identify subjects.
    3. Use of PHI. The research involves only information collection and analysis involving the investigator’s use of identifiable health information when that use is regulated under HIPAA regulations, for the purposes of health care operations, research, or public health activities and purposes (as those purposes are described in the HIPAA regulations).
    4. Use of federally generated or collected information or biospecimens. The research is conducted by, or on behalf of, a federal department or agency using government-generated or government-collected information originally obtained for non- research activities, if the original collection and the secondary use of the information or biospecimens occurs in compliance with three specific federal statues meant to safeguard privacy.

     

    • Secondary means re-using identifiable information and identifiable biospecimens that are collected from some other “primary” or “initial” activity; in other words, not for the purpose of the specific proposed study.
    • “For which consent is not required” is interpreted as there are no federal or state laws that require subject consent for the proposed secondary use. During the original collection of the information or biospecimens, the individuals (if asked) agreed to secondary uses that were described in a manner consistent with the proposed research.
  5. Research and demonstration projects that are conducted or supported by a federal department or agency, or otherwise subject to the approval of department or agency heads (or the approval of the heads of bureaus or other subordinate agencies that have been delegated authority to conduct the research and demonstration projects), and that are designed to study, evaluate, improve, or otherwise examine public benefit or service programs, including procedures for obtaining benefits or services under those programs, possible changes in or alternatives to those programs or procedures, or possible changes in methods or levels of payment for benefits or services under those programs.

    All of the following criteria must be met under this exemption:

    • The program under study delivers a public benefit or service.
    • The project must be conducted pursuant to specific federal statutory authority.
    • There must be no statutory requirement that the project be reviewed by an IRB.
    • The project does not involve significant physical invasions or intrusions upon the privacy of participants.
    • The project does not involve significant physical invasions or intrusions upon the privacy of participants.

     

    Requirement for the federal department or agency conducting or supporting the project. The federal department or agency conducting or supporting the project must establish, on a publicly accessible federal Web site or in such other manner as the department or agency head may determine, a list of the research and demonstration projects the federal department or agency conducts or supports under this exempt category. The department or agency head can determine what sort of information will be included on this list and maintains its oversight. The project must be published on the list before the researcher can begin the project; however, exempt status can be granted before the publication occurs.
  6. Taste and food quality evaluation and consumer acceptance studies:
    1. if wholesome foods without additives are consumed, or
    2. if a food is consumed that contains a food ingredient at or below the level and for a use found to be safe, or agricultural chemical or
    3. environmental contaminant at or below the level found to be safe, by the Food and Drug Administration or approved by the Environmental Protection Agency or the Food Safety and Inspection Service of the Department of Agriculture.
  7. The UD IRB has not implemented exempt determinations under categories 7 and 8 at this time. Brief descriptions are provided here for information purposes

  8. Storage or maintenance for secondary research for which broad consent is required. Storage or maintenance of identifiable private information or identifiable biospecimens for potential secondary research use if an IRB conducts a limited IRB review and makes all of the following determinations:
    1. Broad consent for storage, maintenance, and secondary research use of identifiable private information or identifiable biospecimens is obtained in accordance with the requirements prescribed by the Rule
    2. Broad consent is appropriately documented or waiver of documentation is appropriate.
    3. If there is a change made for research purposes in the way the identifiable private information or identifiable biospecimens are stored or maintained, there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of the data.
  9. Secondary research for which broad consent is required. Research involving the use of identifiable private information or identifiable biospecimens for secondary research use, if all of the following criteria are met:
    1. Broad consent for the storage, maintenance, and secondary research use of the identifiable private information or biospecimens was obtained in accordance with all of the requirements described for exempt category 7.
    2. Documentation of informed consent or waiver of documentation of consent was obtained.
    3. An IRB conducts a limited IRB review and makes the following determinations:
      • When appropriate, there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of the data.
      • The research to be conducted is within the scope of the broad consent provided by the subjects. The investigator does not include returning individual research results to subjects as part of the study plan. (Note: this provision does not prevent an investigator from abiding by any legal requirements to return individual research results.)

 

Expedited Review

Full Board Review

Admin Review

Human Subjects: Life Cycle

New Projects

Here is an overview of the Life Cycle of an IRB Protocol.

All research with human subjects performed by University of Delaware researchers must be reviewed and approved by the UD IRB. Submissions to the University of Delaware IRB must be made using the IRBNet protocol management system (www.irbnet.org). Step-by- step instructions on how to navigate IRBNet and further training on how to use the system can be seen above.

Collaborative Research that involves UD researchers must be submitted to the UD IRB for review even if the project is to be reviewed and approved by another IRB. The submission package must include the approval letter, the protocol form submitted to the other institution as well as the UD protocol form clearly describing the specific role and data access the UD personnel will have in the project.

Student-led projects to be reviewed by the IRB must be shared and signed off in IRBNet by the faculty advisor responsible for the student and project. Student projects will not be reviewed until signed by the faculty advisor in IRBNet.

Any research involving human subjects, bio specimens and/or tissue samples from humans, and/or private identifiable data must be reviewed by an Institutional Review Board (IRB). Submissions for review must be done using IRBNet and all new project application packages must include the protocol form properly filled out and, when applicable, the informed consent document(s), and any other relevant materials (e.g., advertisements, research instruments, surveys, questionnaires, etc.). Forms and templates are available in IRBNet under the “Forms and Templates” tab in the left-hand side menu options.

Once submitted the IRB office will determine the type of review needed. If the project is deemed to be exempt or suitable for an expedited review, the review will be performed on an ongoing basis as the submission is received. Processing times will vary depending on the total workload of the IRB at a given time. When a new project is determined to require full board review it will be added to the next available IRB meeting agenda as it is received. The IRB at UD meets once a month and deadlines for submissions to be considered for review are posted in the research calendar. After review the IRB office will communicate with the principal investigator and request for any clarifications or edits needed to be completed before approval can be issued.

Once a review has been completed, decision letters are uploaded in IRBNet and are always accessible to the investigator(s). Informed consent documents from projects approved via an expedited or full board review will be stamped with the IRB approval and expiration date and also uploaded in IRBNet. Informed consent must be obtained using the stamped version of the approved documents, (i.e., participants signatures need to be collected in a copy of the stamped informed consent). No IRB stamp is added to informed consent documents associated to projects deemed to be exempt.


For questions, send email to: hsrb-research@udel.edu

 

Amendments

Continuing Review

Problems

Audits

Closure

Human Subjects: Data Management and Record Keeping

Informed Consent

Informed Consent Process
and Documentation

Download

Informed Consent Process and Documentation

Informed consent is a process and involves providing a potential subject with adequate information about the research to allow for an informed decision about the subject’s voluntary participation in a research study. Informed consent is a process. Documenting informed consent occurs after explaining the research, addressing any questions, and assessing participant comprehension.

Purpose

Documentation of Informed Consent Regulatory Requirements

Waiver or alteration of Documentation of Informed Consent

Remote Informed Consent Considerations

Documentation of Combined Informed Consent and HIPAA Authorization for research

 

Active

Closure and Retention

Destruction of Records

Questions

Human Subjects: Clinical Trials

Clinical Trial

What is a Clinical Trial?

National Institutes of Health (NIH) generally defines a clinical trial as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.


The definition of clinical trial used is slightly different depending on the requirement:

  1. Per FDAAAApplicable Clinical Trials” generally include prospective interventional studies (with one or more arms) of FDA-regulated drugs, biological products or devicesthat meet one or more of the following conditions (regardless of funding source):
    • The trial has one or more sites in the United States
    • The trial is conducted under an FDA investigational new drug application or investigational device exemption
    • The trial involves a drug, biologic or device that is manufactured in the United States or its territories and is exported for research

    An interactive decision tool of the FDAAA applicable clinical trials definition is offered at https://grants.nih.gov/clinicaltrials_fdaaa/ACTs_under_FDAAA.htm enabling users to identify if the FDA requirements would apply to a specific study.
  2. Per NIH, a Clinical Trial is a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.

  3. The ICMJE defines a clinical trial as any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the cause-and-effect relationship between a health-related intervention and a health outcome. Health-related interventions are those used to modify a biomedical or health-related outcome; examples include drugs, surgical procedures, devices, behavioral treatments, educational programs, dietary interventions, quality improvement interventions and process-of-care changes. Health outcomes are any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events.

For questions, send email to: clinicaltrials@udel.edu.

 

Registration is Required

PI Information

Submit Results

Good to Know

ASSISTANCE

Compliance Hotline
Phone: (302) 831-2792

E: UD IRB Office
P: (302) 831-2137
F: (302) 831-2828

HUMAN SUBJECT LINKS

UD Policy & Procedure Manual
Involvement of Human Subjects in Research and Research-Related Activities

Belmont Report
Ethical principles for the protection of human subjects in research.

Common Rule
The Federal Policy for the Protection of Human Subjects or the “Common Rule” was published in 1991 and codified in separate regulations by 15 Federal departments and agencies, as listed here.

Office of Human Research Protections (OHRP)
United States Department of Health & Human Services Information

FDA Regulations relating to GCP and Clinical Trials